Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
16.7%
% of XLV's 60 holdings also in PPH
43.5%
% of PPH's 26 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 13.8% | 13.4% |
|
JOHNSON & JOHNSON | 7.7% | 7.2% | 7.2% |
|
ABBVIE INC | 6.2% | 6.3% | 6.2% |
|
MERCK & CO. INC. | 4.0% | 4.8% | 4.0% |
|
PFIZER INC | 2.5% | 4.4% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 8.5% |
|
ABBOTT LABORATORIES | 4.6% |
|
INTUITIVE SURGICAL INC | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
AMGEN INC | 3.0% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
GILEAD SCIENCES INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
DANAHER CORP | 2.4% |
|
STRYKER CORP | 2.4% |
XLV Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -5.1% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
|
CENCORA INC | -4.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | -4.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.3% |
|
MCKESSON CORP | -3.8% |
|
ZOETIS INC | -3.4% |